117 results on '"Nguyen, Thi M.-D."'
Search Results
2. A General New Concept for the Development of Opioid Peptide Derived μ-, δ- and κ-Antagonists
3. Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes
4. Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain
5. Conformationally constrained opioid peptide analogs with novel activity profiles
6. Potent Opioid Peptide Agonists Containing 4′-[N-((4′-phenyl)-phenethyl)carboxamido]phenylalanine (Bcp) in Place of Tyr
7. Solid-Phase Azopeptide Diels-Alder Chemistry for Aza-pipecolyl Residue Synthesis To Study Peptide Conformation. IF 4.335
8. Formation Pathways and Opioid Activity Data for 3-Hydroxypyridinium Compounds Derived from Glucuronic Acid and Opioid Peptides by Maillard Processes
9. Conversion of δ-, κ- and μ-receptor selective opioid peptide agonists into δ-, κ- and μ-selective antagonists
10. Differential stereochemical requirements of micro vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists
11. Solid-Phase Azopeptide Diels–Alder Chemistry for Aza-pipecolyl Residue Synthesis To Study Peptide Conformation
12. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-relatedδ-opioid antagonists contains all trans peptide bonds
13. Conformational restriction of the Phe3 residue in a cyclic dermorphin analog: Effects on receptor selectivity and stereospecificity
14. Pharmacological characterization of the dermorphin analog [Dmt 1]DALDA, a highly potent and selective μ-opioid peptide
15. Synthesis and in vitro opioid activity profiles of DALDA analogues
16. Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery
17. Strengthening peptide-based drug activity with novel glyconanoparticle
18. Equipotent enantiomers of cyclic opioid peptides at μ opioid receptor
19. Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.
20. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile
21. A Cyclic Tetrapeptide (“Cyclodal”) and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists
22. Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice
23. The Bifunctional μ Opioid Agonist/Antioxidant [Dmt1]DALDA Is a Superior Analgesic in an Animal Model of Complex Regional Pain Syndrome-Type I.
24. Synthesis and activity profiles of bivalent [Leu5]enkephalin-α-oxymorphamine hybrid opioid receptor ligands
25. Opioid dipeptide derivatives with a mixed μ antagonist/δ antagonist, partial μ agonist/δ antagonist or μ agonist/partial δ agonist profile
26. Impact of the prorenin/renin receptor on the development of obesity and associated cardiometabolic risk factors
27. Link between the prorenin/renin receptor and glucose homeostasis in mice fed a high‐fat/high‐carbohydrate diet
28. Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence
29. Synthesis and biological activity of linear and cyclic enkephalins modified at the Gly3-Phe4amide bond
30. Side chain to side chain cyclization of an enkephalin analog results in loss of opioid receptor selectivity
31. Replacement of the N-terminal Tyrosine Residue in Opioid Peptides with 3-(2,6-Dimethyl-4-carbamoylphenyl)propanoic Acid (Dcp) Results in Novel Opioid Antagonists
32. Characterization of the Binding of [3H][Dmt1]H-Dmt-d-Arg-Phe-Lys-NH2, a Highly Potent Opioid Peptide
33. [2‘,6‘-Dimethyltyrosine]Dynorphin A(1−11)-NH2 Analogues Lacking an N-Terminal Amino Group: Potent and Selective κ Opioid Antagonists
34. Pharmacological characterization of the dermorphin analog [Dmt1]DALDA, a highly potent and selective μ-opioid peptide
35. Novel Ligands Lacking a Positive Charge for the δ- and μ-Opioid Receptors
36. Matrix-assisted laser desorption/ionization mass spectrometric quantification of the mu opioid receptor agonist DAMGO in ovine plasma
37. The Opioid μ Agonist/δ Antagonist DIPP-NH2[Ψ] Produces a Potent Analgesic Effect, No Physical Dependence, and Less Tolerance than Morphine in Rats
38. The TIPP opioid peptide family: Development of ? antagonists, ? agonists, and mixed ? agonist/? antagonists
39. Interaction of agonist peptide [3H]Tyr-d-Ala-Phe-Phe-NH2 with μ-opioid receptor in rat brain and CHO-μ/1 cell line
40. The receptor‐bound conformation of H‐Tyr‐Tic‐(Phe‐Phe)‐OH‐related δ‐opioid antagonists contains all trans peptide bonds
41. Tyrosine-iodination converts the δ-opioid peptide antagonist TIPP to an agonist
42. TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity
43. Conformationally restricted deltorphin analogs
44. The TIPP opioid peptide family: Development of δ antagonists, δ agonists, and mixed μ agonist/δ antagonists.
45. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH related B-opioid antagonists contains all trans peptide bonds
46. Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence.
47. Side chain to side chain cyclization of an enkephalin analog results in loss of opioid receptor selectivity.
48. Synthesis and biological activity of linear and cyclic enkephalins modified at the Gly3-Phe4amide bond.
49. Synthesis of side-chain to side-chain cyclized peptide analogs on solid supports.
50. A novel side-chain-linked antiparallel cyclic dimer of enkephalin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.